Specialty Pharmacy

Nearly 70% of patients with HIV take dietary supplements with their antiretroviral therapy.

Program simulates the physiology of the human body to provide a response model to diseases, medications, and chemicals.

Women given vitamin D3 and calcium supplements had a 30% lower risk of cancer.

Top news of the day from across the health care landscape.

Attendees at the 2017 Asembia Specialty Pharmacy Summit will feature a robust lineup of sessions to obtain pharmacy CE credits.

Determining the composition of HIV’s glycoprotein can help fight the virus.

Legislation would allow community pharmacies to participate in Part D networks if they accept regulations and conditions that other in-network pharmacies operate within.

Selective androgen receptor degraders show promise as treatment for castration-resistant prostate cancer.

Under the ruling, Biogen secured Tecfidera exclusivity through 2028.

Findings may explain why some patients with cancer respond to immunotherapy while others do not.

CMS seeks to support flexibility and efficiency in Medicare Advantage and Part D plans.

A growing number of specialty pharmacy contractual agreements with payers and manufacturers have patient satisfaction metrics built in.

Optimized program can boost adherence and improve reporting capabilities to manufacturers.

After a prolonged court battle, Abu-Jamal will begin treatment for HCV in prison.

Novel drug delivery system steadily releases preventive HIV drugs over an extended period of time.

An artificial intelligence platform detected 92.4% of breast cancer tumors.

Second phase 3 study meets primary endpoint in improving lung cancer survival.

Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

Newly developed framework offers a common ground for specialty pharmacy stakeholders.

Sovaldi plus Harvoni approved to treat HCV in children ages 12 to 17.

Dalfampridine is the only FDA-approved drug to aid walking in patients with MS.

Pharmacy benefit manager takes CVS Health’s role in providing specialty drug management for Federal Employee Program.

Small molecule inhibition of PRMT1 may be an effective therapeutic strategy in pancreatic cancer.

Technique will help scientists develop an effective HIV vaccine.

Stopping immunotherapy after tumor growth may lead to lower survival.

Patients with MS have a high incidence of calcium phosphate stones and struvite stones, study finds.